Text Size

Magnetic Resonance Imaging (MRI) Study of the Hippocampus After Infarction in the Territory of the Middle Cerebral Artery

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by Huazhong University of Science and Technology.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Huazhong University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00867581
First received: March 23, 2009
Last updated: NA
Last verified: March 2009
History: No changes posted

March 23, 2009
March 23, 2009
September 2008
July 2009   (final data collection date for primary outcome measure)
 
 
No Changes Posted
 
 
 
 
 
Magnetic Resonance Imaging (MRI) Study of the Hippocampus After Infarction in the Territory of the Middle Cerebral Artery
To Observe Delayed Neuronal Death of Hippocampus After Middle Cerebral Artery Infarction Through Magnetic Resonance Imaging(MRI) Volume Measurement and Magnetic Resonance Spectroscopy(MRS) Study of Hippocampus

The purpose of this study is to observe delayed neuronal death of hippocampus after middle cerebral artery infarction in human beings.

40 patients with middle cerebral artery infarction and 40 healthy volunteers will be observed. All of them will receive MRI scan and the assessment of the neuropsychological function (MMSE, AVLT, HAMD) intending to observe delayed neuronal death of hippocampus after middle cerebral artery infarction in human beings.
Observational
Observational Model: Case Control
Time Perspective: Cross-Sectional
 
Non-Probability Sample

chronic-stage patients of unilateral middle cerebral artery infarction
Ischemic Stroke
 
  • 1
    chronic-stage patients after infarction in the territory of unilateral middle cerebral artery
  • 2
    age, sex and risk factor matched volunteers without ischemic stroke
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
80
 
July 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinical diagnosis of middle cerebral artery infarction
  • At least six months from the stroke
  • Must be able to measure his(her) neuropsychologic function (by MMSE, AVLT)

Exclusion Criteria:

  • Unable to undergo examinations due to disturbances of consciousness or medical conditions
  • Severe dementia, apraxia, disturbances of sensation or perception
  • Serious complications including severe heart failure, hepatic dysfunction, renal insufficiency,or shock
  • Parkinson's disease, malignant tumor, autoimmune diseases
Both
 
Yes
Contact: Wei Wang, Doctor 86-027-8366-3648 wwang_tjh@126.com
China
 
NCT00867581
30725019-2
Yes
Wei Wang, Department of Neurology of Tongji Hospital, Huazhong University of Sci. and Tec
Huazhong University of Science and Technology
 
Principal Investigator: Wei Wang, Doctor Huazhong University of Science and Technology
Huazhong University of Science and Technology
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP